Candel Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.02 |
4.35 |
92.50 |
46.36 |
165.50 |
395.68 |
| Przychód Δ r/r |
0.00% |
27952.85% |
2027.32% |
-49.88% |
256.97% |
139.08% |
| Przychód (min) |
0.02 |
4.35 |
92.50 |
45.30 |
165.50 |
395.68 |
| Przychód (max) |
0.02 |
4.35 |
92.50 |
47.43 |
165.50 |
395.68 |
| EBITDA (średnia) |
-0.00 |
-0.87 |
-18.50 |
-9.27 |
-33.10 |
-79.14 |
| EBIT (średnia) |
-0.00 |
-0.87 |
-18.50 |
-9.27 |
-33.10 |
-79.14 |
| EBIT % |
-19.99% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-43.37 |
-15.14 |
-21.54 |
-11.05 |
37.27 |
96.40 |
| Zysk netto % |
-279821.72% |
-348.21% |
-23.29% |
-23.83% |
22.52% |
24.36% |
| EPS (średnia) |
-1.37 |
-0.48 |
-0.68 |
-0.30 |
1.18 |
3.04 |
| Liczba analityków (Przychody) |
1 |
2 |
5 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
2 |
1 |
3 |
4 |
3 |
2 |
| symbol |
CADL |
CADL |
CADL |
CADL |
CADL |
CADL |